Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Future Fields Cellular Agriculture And Research Ltd. currently faces 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed among 2 distinct examiners and 2 distinct art units. This distribution indicates that each pending application is being reviewed by a different examiner in a separate administrative unit, requiring a tailored approach for each filing within the biotechnology sector.
WEHBE, ANNE MARIE SABRINA is the busiest examiner for the company, with 1 busiest examiner pending office action. This accounts for 1 of the 2 pending office actions in the portfolio. The involvement of 2 distinct art units suggests a variety of technical focuses in the company's current patent filings. Because there are 2 distinct examiners involved, the company must manage different examination styles to successfully navigate the 2 pending office actions currently on their docket.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WEHBE, ANNE MARIE SABRINA | 1 | 57.3% | +43.3% |
| MARVICH, MARIA | 1 | 55.0% | +28.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18643639 | METHOD FOR PRODUCING RECOMBINANT PROTEINS IN INSECTS | WEHBE, ANNE MARIE SABRINA | — |
| 18541697 | SYSTEM AND METHOD FOR REARING A GENETICALLY-MODIFIED FLY POPULATION TO REGULATE PRODUCTION OF A TARGET COMPOUND | MARVICH, MARIA | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18643639 | METHOD FOR PRODUCING RECOMBINANT PROTEINS IN INSECTS | WEHBE, ANNE MARIE SABRINA | 1633 | §112DP | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18541697 | SYSTEM AND METHOD FOR REARING A GENETICALLY-MODIFIED FLY POPULATION TO REGULATE PRODUCTION OF A TARGET COMPOUND | MARVICH, MARIA | 1634 | §112 | Non-Final OA | — | Pending | Dec 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFuture Fields Cellular Agriculture And Research Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Anne Marie Sabrina Wehbe has the most, with 1 of Future Fields Cellular Agriculture And Research Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
